Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to compare patients with aneurysmal subarachnoid hemorrhage
on dexmedetomidine compared to propofol to assess if one group has decreased inflammation.
The investigators hypothesis is that the group assigned to receive dexmedetomidine will have
a more profound decrease in markers of inflammation over time.